An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Lecithin cholesterol acyltransferase (LCAT) plays a key role in the reverse cholesterol transport (RCT) process by converting cholesterol to cholesteryl ester to form mature HDL particles, which in turn deliver cholesterol back to the liver for excretion and catabolism. HDL levels in human plasma are negatively correlated with cardiovascular risk and HDL functions are believed to be more important in atheroprotection. This study investigates whether and how D-4F, an apolipoprotein A-I (apoA-I) mimetic peptide, influences LCAT activity in the completion of the RCT process. We demonstrated that the apparent rate constant value of the LCAT enzyme reaction gives a measure of LCAT activity and determined the effects of free metals and a reducing agent on LCAT activity, showing an inhibition hierarchy of Zn(2+)>Mg(2+)>Ca(2+) and no inhibition with beta-mercaptoethanol up to 10 mM. We reconstituted nano-disc particles using apoA-I or D-4F with phospholipids. These particles elicited good activity in vitro in the stimulation of cholesterol efflux from macrophages through the ATP-binding cassette transporter A1 (ABCA1). With these particles we studied the LCAT activity and demonstrated that D-4F did not activate LCAT in vitro. Furthermore, we have done in vivo experiments with apoE-null mice and demonstrated that D-4F (20 mg/kg body weight, once daily subcutaneously) increased LCAT activity and HDL level as well as apoA-I concentration at 72 hours post initial dosing. Finally, we have established a correlation between HDL concentration and LCAT activity in the D-4F treated mice.
Chen
Xun
X
Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Burton
Charlotte
C
Song
Xuelei
X
McNamara
Lesley
L
Langella
Annunziata
A
Cianetti
Simona
S
Chang
Ching H
CH
Wang
Jun
J
D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism; D000818:Animals; D016632:Apolipoprotein A-I / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D015153:Blotting, Western; D002413:Cations, Divalent / Q000494:pharmacology; D002460:Cell Line; D002850:Chromatography, Gel; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008075:Lipoproteins, HDL / Q000378:metabolism*; D051379:Mice; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000378:metabolism*
C577836:ABCA1 protein, human; D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D016632:Apolipoprotein A-I; D002413:Cations, Divalent; C465468:D-4F peptide; D008075:Lipoproteins, HDL; D007862:Phosphatidylcholine-Sterol O-Acyltransferase
Circulation. 1999 Oct 26;100(17):1816-22
10534470
Curr Opin Investig Drugs. 2007 Mar;8(3):201-12
17408115
Circulation. 2004 Jun 29;109(25):3215-20
15197147
Circ Res. 2006 Jun 9;98(11):1352-64
16763172
Clin Investig. 1994 Dec;72(12):951-6
7711425
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4855-9
2052566
Atherosclerosis. 1997 May;131(1):85-95
9180249
Curr Opin Investig Drugs. 2002 Mar;3(3):420-6
12054090
J Biol Chem. 2005 Jan 14;280(2):1669-77
15516341
J Clin Invest. 1994 Jan;93(1):321-30
8282802
Biochemistry. 2007 Oct 2;46(39):11158-68
17824618
Biochim Biophys Acta. 1972 Aug 11;270(4):513-8
4340992
FEBS Lett. 1999 Mar 19;447(1):106-10
10218592
Biochem J. 2007 Apr 15;403(2):359-67
17206937
Nat Med. 1997 Jul;3(7):744-9
9212100
Cell. 1992 Oct 16;71(2):343-53
1423598
J Biol Chem. 2005 Jan 14;280(2):1193-8
15533931
Circ Res. 2004 Oct 15;95(8):764-72
15486323
Circulation. 2002 Jan 22;105(3):290-2
11804981
Biochim Biophys Acta. 1996 May 31;1301(1-2):115-26
8652646
Circulation. 1994 Oct;90(4):1935-41
7923682
Circulation. 2001 Jun 26;103(25):3047-50
11425766
J Biol Chem. 2000 Jun 30;275(26):19707-12
10781581
J Lipid Res. 1995 Feb;36(2):211-28
7751809
Artery. 1991;18(6):326-40
1750805
Science. 1996 Jan 26;271(5248):518-20
8560269
J Lipid Res. 1984 Oct;25(10):1017-58
6392459
Nature. 2006 May 18;441(7091):358-61
16710421
Nat Clin Pract Endocrinol Metab. 2006 Sep;2(9):504-11
16957764
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11448-53
8876155
Rev Endocr Metab Disord. 2004 Dec;5(4):311-8
15486463
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9774-9
15210959
JAMA. 2003 Nov 5;290(17):2292-300
14600188
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):434-8
1703299
J Clin Invest. 1994 Aug;94(2):899-903
8040345
J Lipid Res. 2001 Jul;42(7):1096-104
11441137
Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):450-8
10669643
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):245-56
11111093
Science. 1986 Apr 4;232(4746):34-47
3513311
J Mol Med (Berl). 2006 Apr;84(4):276-94
16501936